What is the first line treatment for unstable angina?

1. Australian Institute of Health and Welfare. Cardiovascular disease: Australian facts 2011. Cardiovascular disease series no 35. Cat. No. CVD 53. Canberra: AIHW; 2011. www.aihw.gov.au/publication-detail/?id=10737418510 [cited 2015 Jul 1]

2. Abrams J. Clinical practice. Chronic stable angina. N Engl J Med 2005;352:2524-33. [PubMed] [Google Scholar]

3. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al.Task Force Members. ESC Committee for Practice Guidelines. Document Reviewers . 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949-3003. [PubMed] [Google Scholar]

4. Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, et al.European Society of Cardiology (ESC) European Atherosclerosis Society (EAS) . ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 2011;217:3-46. [PubMed] [Google Scholar]

5. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al.American College of Cardiology Foundation. American Heart Association Task Force on Practice Guidelines. American College of Physicians. American Association for Thoracic Surgery. Preventive Cardiovascular Nurses Association. Society for Cardiovascular Angiography and Interventions. Society of Thoracic Surgeons . 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012;60:e44-164. [PubMed] [Google Scholar]

6. Heart Outcomes Prevention Evaluation Study Investigators . Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy [Erratum in: Lancet 2000;356:860]. Lancet 2000;355:253-9. [PubMed] [Google Scholar]

7. Norhammar A, Lagerqvist B, Saleh N. Long-term mortality after PCI in patients with diabetes mellitus: results from the Swedish Coronary Angiography and Angioplasty Registry. EuroIntervention 2010;5:891-7. [PubMed] [Google Scholar]

8. Emond M, Mock MB, Davis KB, Fisher LD, Holmes DR, Jr, Chaitman BR, et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 1994;90:2645-57. [PubMed] [Google Scholar]

9. Hjemdahl P, Eriksson SV, Held C, Forslund L, Näsman P, Rehnqvist N. Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS). Heart 2006;92:177-82. [PMC free article] [PubMed] [Google Scholar]

10. Ashley EA, Myers J, Froelicher V. Exercise testing in clinical medicine. Lancet 2000;356:1592-7. [PubMed] [Google Scholar]

11. Schinkel AF, Bax JJ, Geleijnse ML, Boersma E, Elhendy A, Roelandt JR, et al. Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography? Eur Heart J 2003;24:789-800. [PubMed] [Google Scholar]

12. Califf RM, Armstrong PW, Carver JR, D’Agostino RB, Strauss WE. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. J Am Coll Cardiol 1996;27:1007-19. [PubMed] [Google Scholar]

13. Prasad A, Rihal C, Holmes DR, Jr. The COURAGE trial in perspective. Catheter Cardiovasc Interv 2008;72:54-9. [PubMed] [Google Scholar]

14. Rihal CS, Raco DL, Gersh BJ, Yusuf S. Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations. Circulation 2003;108:2439-45. [PubMed] [Google Scholar]

15. Hemingway H, Crook AM, Feder G, Banerjee S, Dawson JR, Magee P, et al. Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization. N Engl J Med 2001;344:645-54. [PubMed] [Google Scholar]

16. Lin FY, Dunning AM, Narula J, Shaw LJ, Gransar H, Berman DS, et al. Impact of an automated multimodality point-of-order decision support tool on rates of appropriate testing and clinical decision making for individuals with suspected coronary artery disease: a prospective multicenter study. J Am Coll Cardiol 2013;62:308-16. [PubMed] [Google Scholar]

17. Raggi P, Gongora MC, Gopal A, Callister TQ, Budoff M, Shaw LJ. Coronary artery calcium to predict all-cause mortality in elderly men and women. J Am Coll Cardiol 2008;52:17-23. [PubMed] [Google Scholar]

18. Min JK, Dunning A, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, et al.CONFIRM Investigators . Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol 2011;58:849-60. [PubMed] [Google Scholar]

19. Jacq L, Chabredier-Paquot C, Pezzano M, Caussin C, Habis M, Schaison F, et al. [Prognostic value of normal coronary angiography] [French.]. Ann Cardiol Angeiol (Paris) 2001;50:404-7. [PubMed] [Google Scholar]

20. Ostrom MP, Gopal A, Ahmadi N, Nasir K, Yang E, Kakadiaris I, et al. Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography. J Am Coll Cardiol 2008;52:1335-43. [PubMed] [Google Scholar]

21. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003;348:1322-32. [PubMed] [Google Scholar]

22. Ciszewski A, Bilinska ZT, Brydak LB, Kepka C, Kruk M, Romanowska M, et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J 2008;29:1350-8. [PubMed] [Google Scholar]

23. Horowitz JD, Mashford ML. Perhexiline maleate in the treatment of severe angina pectoris. Med J Aust 1979;1:485-8. [PubMed] [Google Scholar]

24. Bangalore S, Bhatt DL, Steg PG, Weber MA, Boden WE, Hamm CW, et al. β-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial. Circ Cardiovasc Qual Outcomes 2014;7:872-81. [PubMed] [Google Scholar]

25. Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-31. [PubMed] [Google Scholar]

26. Parker JD, Parker JO. Nitrate therapy for stable angina pectoris. N Engl J Med 1998;338:520-31. [PubMed] [Google Scholar]

27. IONA Study Group . Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 2002;359:1269-75. [PubMed] [Google Scholar]

28. McDaid J, Reichl C, Hamzah I, Fitter S, Harbach L, Savage AP. Diverticular fistulation is associated with nicorandil usage. Ann R Coll Surg Engl 2010;92:463-5. [PMC free article] [PubMed] [Google Scholar]

29. Fox K, Ford I, Steg PG, Tendera M, Ferrari R, BEAUTIFUL Investigators . Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 2008;372:807-16. [PubMed] [Google Scholar]

30. Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R, SIGNIFY Investigators . Ivabradine in stable coronary artery disease without clinical heart failure. N Engl J Med 2014;371:1091-9. [PubMed] [Google Scholar]

31. Tardif JC, Ponikowski P, Kahan T, ASSOCIATE Study Investigators . Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial. Eur Heart J 2009;30:540-8. [PMC free article] [PubMed] [Google Scholar]

32. Ashrafian H, Horowitz JD, Frenneaux MP. Perhexiline. Cardiovasc Drug Rev 2007;25:76-97. [PubMed] [Google Scholar]


Page 2

Risk stratification by CT coronary angiography 12,16,18-20

Risk of cardiovascular eventAngiographic findings
HighDisease of left main or left anterior descending coronary artery, three-vessel disease with proximal stenoses
IntermediateSignificant lesion in large and proximal coronary artery, but no high-risk features
LowNormal coronary artery or non-obstructive plaques